Literature DB >> 881623

Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons.

D C Eikenburg, A J Ravitz, G A Gudelsky, K E Moore.   

Abstract

Serum prolactin concentrations and dopamine turnover in the striatum and median eminence were studied in male rats after the administration of estradiol benzoate. The alpha-methyltyrosine-induced reduction of dopamine concentrations in these brain regions was used to evaluate relative rates of turnover. Steady state dopamine concentrations in the median eminence and striatum were not altered by 1, 3 or 5 days of estradiol treatment. However, 3 or 5 days of estradiol administration enhanced dopamine turnover in the median eminence but not in the striatum. Estradiol treatment failed to alter dopamine turnover in the median eminence of hypophysectomized rats. Estradiol increased serum prolactin concentrations at all of the times examined. Although alpha-methyltyrosine also increased serum prolactin, this increase was further enhanced in estradiol-treated rats. The increased prolactin response to alpha-methyltyrosine and increased dopamine turnover in the median eminence of estradiol-treated rats suggests that tuberoinfundibular dopaminergic neurons may be part of a hormonal-neuronal negative feedback loop which functions to regulate prolactin secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 881623     DOI: 10.1007/bf01257017

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  17 in total

1.  Effects of dexamethasone on phenylethanolamine N-methyltransferase and adrenaline in the brains and superior cervical ganglia of adult and neonatal rats.

Authors:  K E Moore; O T Phillipson
Journal:  J Neurochem       Date:  1975-09       Impact factor: 5.372

2.  Microfluorimetric quantitation of catecholamine fluorescence in rat median eminence. I. Aspects on the distribution of dopamine and noradrenaline nerve terminals.

Authors:  A Löfström; G Jonsson; K Fuxe
Journal:  J Histochem Cytochem       Date:  1976-02       Impact factor: 2.479

3.  Estrogen stimulation of prolactin production by rat adenohypophysis in vitro.

Authors:  C S NICOLL; J MEITES
Journal:  Endocrinology       Date:  1962-02       Impact factor: 4.736

4.  Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.

Authors:  A O Donoso; W Bishop; C P Fawcett; L Krulich; S M McCann
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

5.  Castration, sex hormones, and tubero-infundibular dopamine neurons.

Authors:  K Fuxe; T Hökfelt; O Nilsson
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

6.  The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain.

Authors:  A Björklund; R Y Moore; A Nobin; U Stenevi
Journal:  Brain Res       Date:  1973-03-15       Impact factor: 3.252

7.  Fluorescence histochemical and microspectrofluorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon.

Authors:  A Björklund; A Nobin
Journal:  Brain Res       Date:  1973-03-15       Impact factor: 3.252

8.  Factors involved in the control of the activity of the tubero-infundibular dopamine neurons during pregnancy and lactation.

Authors:  K Fuxe; T Hökfelt; O Nilsson
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

9.  Effects of central acting drugs on serum and pituitary prolactin levels in rats.

Authors:  K H Lu; Y Amenomori; C L Chen; J Meites
Journal:  Endocrinology       Date:  1970-10       Impact factor: 4.736

10.  Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.

Authors:  G A Gudelsky; E K Moore
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

View more
  9 in total

Review 1.  The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

2.  Reduced tuberoinfundibular dopaminergic neuronal function in rats after long-term withdrawal of estrogen treatment.

Authors:  L Annunziato; D Cocchi; G di Renzo; G L Rossi; S Amoroso; M Taglialatela; E E Müller
Journal:  Experientia       Date:  1986-04-15

Review 3.  Sex differences in kappa opioid pharmacology.

Authors:  Khampaseuth Rasakham; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2010-10-14       Impact factor: 5.037

4.  Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: studies in rats with complete hypothalamic deafferentations.

Authors:  G A Gudelsky; L Annunziato; K E Moore
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

5.  Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors.

Authors:  K A Elias; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Studies on estrogen induced pituitary tumor in the rat with special reference to the relationship of the tuberoinfundibular dopamine neuron system.

Authors:  M Fujimoto; E Yoshino; K Hirakawa; K Chihara; Y Ibata
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

7.  Effect of estradiol-17 beta on the cytology of the liver, gonads and pituitary, and on plasma electrolytes in the female freshwater eel.

Authors:  M Olivereau; J Olivereau
Journal:  Cell Tissue Res       Date:  1979-07-17       Impact factor: 5.249

Review 8.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

9.  Natural and molecular history of prolactinoma: insights from a Prlr-/- mouse model.

Authors:  Valérie Bernard; Chiara Villa; Aurélie Auguste; Sophie Lamothe; Anne Guillou; Agnès Martin; Sandrine Caburet; Jacques Young; Reiner A Veitia; Nadine Binart
Journal:  Oncotarget       Date:  2017-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.